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ABSTRACT
INTRODUCTION: Modern analytical chemistry is heading to the side of the “Green Chemistry” approach. 
The implementation of the current approach is in the development of fast analytical methods that combine 
the determination of several compounds with the utilization of methods that do not generate wastes of or-
ganic solvents.  
AIM: The aim of the current work was to develop a method for the simultaneous determination of benzyda-
mine hydrochloride (API) and methyl parahydroxybenzoate (preservative) in the dosage form. 
MATERIALS AND METHODS: The development and validation of the proposed methodology were car-
ried out. 
RESULTS AND DISCUSSION: The validation parameters were determined; it was shown that the tech-
nique is robust, specific to determinable analytes. 
CONCLUSION: The developed technique can be used in control laboratories for the simultaneous deter-
mination of benzydamine hydrochloride and methyl parahydroxybenzoate in the finished dosage form of 
benzydamine.
Keywords: benzydamine hydrochloride, methyl parahydroxybenzoate, gas chromatography, method vali-
dation, simultaneous determination
INTRODUCTION
Benzydamine in the form of hydrochloride 
is an active pharmaceutical ingredient used for the 
dosage forms applied for the treatment of inflamma-
tory diseases of the oral cavity. It also has analgesic 
and antipyretic properties (1,2). Preparations based 
on benzydamine are used in postoperative therapy, 
as well as for the treatment of post-traumatic pains 
and effusions (3,4).
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AIM
The development of an express method for the 
determination of benzydamine and methylparaben 
in an oromucosal spray was an actual task, from the 
point of Green chemistry principles complement and 
the perspective of analytical control development at 
pharmaceutical enterprises.
MATERIALS AND METHODS
1. Chemicals and Reagents
Chloroform (GC grade) was supplied by Sig-
ma Aldrich (Germany). Benzydamine hydrochloride 
reference standard, impurity A standard and meth-
ylparaben reference standards were purchased as per 
the British pharmacopeia standards. 
2. Apparatus and Software
Chromatography was carried out using Agi-
lent 7890 gas chromatograph with flame ionization 
detector, autosampler, and injector with split mode. 
Chemstation software was used for data acquisition.
3. Chromatographic conditions
  injector: temperature 300°C, split 1:20;
  column: HP-5 (3.0 m x 0.32 mm) with film 
thickness 0.25 μm;
  carrier gas: helium;
  detector: FID, temperature 300°C;
  oven program: initial temperature of 220°C for 
5 minutes, the gradient at a rate of 20°C/min to 
a temperature of 270°C and an exposure time of 
10 minutes; 
  flow rate: 3 mL/min;
  injection volume: 1 μL.
RESULTS 
1. Method Development
1.1. Selection of Extraction Conditions and Inter-
nal Standard
The development of the methodology began 
with the selection of conditions for sample prepara-
tion of the substances. The Pharmacopoeia mono-
graph describes the use of chloroform extraction, af-
ter the introduction of alkali into the test solution. 
However, this sample-preparation procedure is not 
suitable for the determination of methylparaben, 
since pH values  of the solution greater than 8.0 lead 
to degradation of the molecule, which will lead to the 
impossibility of subsequent quantification of an an-
Fig. 1. Structure of benzydamine hydrochloride
Fig. 2. Structure of methylparaben
For oromucosal sprays, as for dosage forms of 
multiuse, it is necessary to use antimicrobial preser-
vatives that inhibit the growth of microorganisms in 
the product (5). One of the most common preserva-
tives for oral dosage forms is the methyl ester of para-
hydroxybenzoic acid (methylparaben) (6). Methyl-
paraben shows activity against yeast and mold fun-
gi, against gram-positive and gram-negative micro-
organisms (7).
High performance liquid chromatography 
(HPLC) determination of active substances and pre-
servatives in pharmaceutical analysis has a dominant 
role due to the versatility of the method and the abil-
ity to determine the broad spectrum of non-volatile 
substances. However, the drawback of the method is 
the need for organic solvents and additives utiliza-
tion, which are not only economically expensive but 
also harmful to the environment and the staff of con-
trol laboratories.
Compared with the HPLC method, gas chro-
matography has a number of undeniable advantag-
es, which are the speed of the method, relatively low 
cost, as well as environmental impact. Thus, the use 
of inert carrier gases instead of toxic solvents, mod-
ified with salts of organic acids and bases, a smaller 
volume of the injected sample, the speed of analysis, 
and the use of highly effective capillary columns cor-
relate with the need to comply with the principles of 
Green chemistry.
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alyte. In the process of the extraction conditions se-
lection, it was found that the optimum pH of the me-
dium is 6.0-7.0. Under these conditions, the degrada-
tion of the desired molecules does not occur, and the 
substances completely migrate to an organic solvent. 
Chloroform was used as the organic solvent. As an 
internal standard, a by-product of benzydamine hy-
drochloride synthesis - an impurity A was chosen, 
whose aqueous solution was prepared at a concentra-
tion equal to the concentration of benzydamine in 
the dosage form (1.5 mg/mL).  
Thus, 5 mL of the test preparation was taken 
for the analysis, 5 mL of internal standard solution 
and 10 mL of chloroform were added. After inten-
sive mixing, the solution was decanted and the or-
ganic layer was separated by a separatory funnel. The 
chloroform extract was subsequently used as the test 
solution.
1.2. Selection of Concentrations of Test Solutions
The initial concentrations of benzydamine hy-
drochloride and methylparaben in the drug were 1.5 
and 1 mg/mL, respectively. After sample prepara-
tion, in the final solution, the concentration of the 
analytes was 0.15 and 0.1 mg/mL, which corresponds 
to a concentration of 0.15 and 0.1 μg/μL during chro-
matography. With such quantities, no overload of 
the column was observed; the peaks had an accept-
able symmetry. Therefore, for the final method, such 
concentrations of substances in the test solution were 
chosen.
1.3. Screening of the Stationary Phase
The polarity of the stationary phase is a key 
factor for the successful separation of components 
in gas chromatography. When using columns with 
phase polarity, different from the polarity of the an-
alytes, it can lead to peak broadening, poor reten-
tion, and unsatisfactory selectivity of the technique, 
which finally leads to incorrect results of quantifi-
cation of the components being determined. There-
fore, the choice of a stationary phase is a key factor 
in the analysis. Since benzydamine and methylpara-
ben are high-boiling substances, when choosing a 
column, we considered selection of thermally stable 
phases. In the screening, phases of different polarity 
were used: HP-IINNOWAX (PEG), HP-FFAP (PET 
bound to nitroterephthalic acid), DB-624 (6% cyano-
propylphenyl / 94% Dimethyl (poly) siloxane), and 
HP-5 (5% Diphenyl / 95% Dimethyl (poly) siloxane).
For separable analytes, the best selectivity and 
symmetry of the substances to be detected were ob-
served when using the nonpolar HP-5 phase with a 
column geometry of 30 m x 0.32 mm x 0.25 μm.
1.4. Selecting the Parameters of the Injector
To avoid column overloading, 1 μL of the test 
solution was injected into the chromatograph. Tak-
ing into account the concentration of the analytes in 
the test solution, the 1:20 split was chosen. Regarding 
the high boiling temperatures of benzydamine and 
methylparaben (474°C  and 265°C, respectively), as 
well as a significant difference in the boiling point, it 
was necessary to select the temperature of the injec-
tor so that it allowed the analytes to evaporate even-
ly and at the same time without a discrimination of 
the sample. Three temperatures (230°C, 270°C, and 
300° C) were tested. In this case, the first 2 options 
did not provide sufficient energy for the evaporation 
of benzydamine. At 300°C, a sufficient reproducibil-
ity of the peak areas without degradation of the ana-
lytes was observed.
As an insert in the evaporator, a liner was used 
with the deactivated glass fiber placed therein.
1.5 Choice of the Chromatography Temperature 
Program
In case of a difference of boiling points of the 
analytes, as well as a difference in chemical proper-
ties, the isothermal mode of separation gave a sig-
nificant difference in the retention times of benzy-
damine and methylparaben. During preliminary 
studies, it was established that methylparaben elutes 
at a temperature of 220°C. At this temperature, the 
time of benzydamine retention is about 30 minutes. 
The optimal temperature for the elution of benzy-
Fig. 3. Chromatogram of benzydamine and methylpara-
ben on an HP-5 column
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damine was 270°C. Therefore, during the develop-
ment of the temperature gradient, a thermostat pro-
gram was set with an initial temperature of 220°C for 
5 minutes and further increase at a rate of 20°C/min 
to a temperature of 270°C and an exposure time of 
10 minutes.
To prevent condensation of the sample in the 
detector, its temperature was set at 30°C higher than 
the final temperature of the thermostat.
2. Validation of the GC Method
The validation of the methodology was carried 
out for the next parameters:
  specificity;Fig. 4. Linearity of benzydamine hydrochloride
Parameter Symbol Obtained Value Acceptance Criteria
Correlation coefficient R 0.9996 ≥ 0.99810
Intercept А 1.0228 ≤ 2.6
Standard deviation SA 0.4779I -
Slope В 1.0023 -
Table 1. Linearity parameters for benzydamine hydrochloride
Model Solutions
Concentration of 














М1 0.312 80.00 79.57 99.46
M2 0.332 85.00 84.75 99.71
M3 0.351 90.00 89.66 99.63
M4 0.371 95.00 95.15 100.16
M5 0.390 100.00 99.96 99.96
M6 0.410 105.00 104.62 99.63
M7 0.429 110.00 109.47 99.52
M8 0.449 115.00 114.18 99.29
M9 0.468 120.00 120.40 100.33
Average, Z, % 99.79
Standard deviation, SDz, % 0.34
Confidence interval for repeatability 
∆ = t(95%,8). SDz = 1.8595
.SDz, %
0.63
Critical value for results
∆ ≤ max∆As  = 1.6 %
Comply
(0.63 < 1.6)
Systematic error δ= |Z - 100|, % 0.21
Criterion of insignificance of systematic error δ≤ max δ% Comply(0.21 < 0.51)
Table 2. Results of accuracy for benzydamine hydrochloride
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2.1. Evaluation of the Linearity of the Method for 
Benzydamine
For 9 model solutions of benzydamine hydro-
chloride, the least-squares method was used to deter-
mine the ratio of the amount found of benzydamine 
hydrochloride (Y) on the given amount (X), i.e. De-
pendence of the form Y = BX + A.
Obtained results show that the method is linear 
for benzydamine hydrochloride.
2.2. Evaluation of Accuracy for Benzydamine  
9 model solutions of benzydamine were inject-
ed in triplicate. The results are given in Тable 2.
Fig. 5. Linearity of methylparaben
Parameter Symbol Obtained Value Acceptance Criteria
Correlation coefficient R 0.9999 ≥ 0.9924
Intercept А 0.0987I ≤ 5.1
Standard deviation SA 0.4779I -
Slope В 1.0023 -
Table 3. Linearity parameters for methylparaben
Model Solutions
Concentration of 














М1 99.84 80.00 79.87 99.84
M2 99.68 85.00 84.73 99.68
M3 99.43 90.00 89.49 99.43
M4 99.85 95.00 94.86 99.85
M5 99.96 100.00 99.96 99.96
M6 99.77 105.00 104.76 99.77
M7 99.77 110.00 109.74 99.77
M8 99.74 115.00 114.70 99.74
M9 99.73 120.00 119.68 99.73
Average, Z, % 99.75
Standard deviation, SDz, % 0.15
Confidence interval for repeatability 
∆ = t(95%,8). SDz = 1.8595
.SDz, %
0.28
Critical value for results
∆ ≤ max∆As = 1.6%
Comply
(0.28 < 3.2)
Systematic error δ=|Z - 100|, % 0.25
Criterion of insignificance of systematic error δ≤ max δ% Comply(0.25 < 1.02)
Table 4. Results of accuracy and repeatability for methylparaben
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Thus, the obtained results show sufficient accu-
racy and repeatability of the method. 
2.3. Evaluation of the Linearity for Methylparaben
For 9 model solutions of methylparaben, the 
least-squares method was used to determine the ra-
tio of the amount found of methylparaben (Y) on the 
given amount (X), i.e. Dependence of the form Y = 
BX + A.
Obtained results show that the method is linear 
for methylparaben.
2.4. Evaluation of Accuracy for Methylparaben 
9 model solutions of methylparaben were in-
jected in triplicate. The results are given in Table 4.
2.5. Evaluation of the Repeatability for Benzyda-
mine and Methylparaben
The repeatability was evaluated by injection in 
triplicate of one reference solution and six test solu-
tions, prepared from one sample of the preparation. 
The obtained experimental data are given in Table 5, 
6 for the benzydamine hydrochloride and in Table 7, 
8 for methylparaben.
2.6. Specificity
To show the specificity, a solvent and a placebo 
solution of the drug were injected. No interference 
was observed between the peaks of methylparaben, 
the internal standard, and benzydamine with peaks 
Name of the Solution Average Area (S) RSD S, (%) X, mg/mL
TS1 211.52 0.56 1.521
TS2 223.15 0.68 1.512
TS3 209.52 0.79 1.519
TS4 215.85 0.44 1.525
TS5 213.54 0.72 1.509
TS6 217.85 0.65 1.51
RS 232.54 0.55 -
Average 1.516
RSD, % 0.43
Table 5. Results for repeatability for benzydamine hydrochloride
Parameter Symbol Analyte Obtained Value Acceptance Criteria
Relative standard deviation of 
six parallel injections, % RSD
Benzydamine 
hydrochloride 0.43 ≤ 1.4 %
Table 6. Acceptance criteria
Name of the Solution Average Area (S) RSD S, (%) X, mg/mL
TS1 263.35 0.79 1.031
TS2 255.22 0.81 1.023
TS3 258.65 0.54 1.029
TS4 254.19 0.64 1.042
TS5 254.89 0.68 1.046
TS6 253.85 0.75 1.039
RS 274.84 0.74 -
Average 1.035
RSD, % 0.84
Table 7. Results for repeatability for methylparabene
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of placebo. The retention times of the analytes were 
compared with the retention times of the standard 
samples of benzydamine hydrochloride, methylpara-
ben, and impurity A of benzydamine. In the chro-
matograms of the test solution, there was no inter-
ference between peaks of the analyzed components. 
Consequently, the method is specific to the defined 
analytes.
DISCUSSION
The aim of this study was to develop a meth-
odology for the simultaneous determination of ben-
zydamine hydrochloride and methylparaben in the 
finished dosage form of benzydamine hydrochloride 
with the implementation of the gas chromatography 
method. 
The determination of benzydamine hydrochlo-
ride and methylparaben is described separately in lit-
erature and has not been studied simultaneously by 
far.
In routine control of benzydamine hydrochlo-
ride, chromatographic methods are used, mainly 
HPLC (8-10). A method for the spectrophotometric 
determination of benzydamine after the formation 
of the ion-pair complex with methyl orange has also 
been described (11). The monograph of the British 
Pharmacopeia describes the quantitative determi-
nation of benzydamine by gas chromatography us-
ing the extraction of an alkaline solution of benzyda-
mine and packed columns with the OV-17 phase (12).
The determination of methylparaben in drug 
combinations also occurs predominantly by HPLC 
(13-15).
The gas chromatographic determination of 
methylparaben is described in combination with 
other preservatives in liquid products, as well as af-
ter derivatization with anhydrides of aliphatic acids 
with following micro extraction (16).
The basis of the method was taken from the 
monograph of the British Pharmacopeia for the de-
termination of benzydamine in the finished dosage 
form. During the method development process, the 
optimal extraction conditions, the temperature of the 
injector, the detector, the flow velocity of the mobile 
phase, the stationary phase, the type of sample injec-
tion, and the temperature gradient were selected. 
Validation of the method was carried out ac-
cording to ICH Q2 guidance. All validated parame-
ters were within the acceptance criteria. The method 
is linear for all compounds with a correlation coeffi-
cient of more than 0.999.
CONCLUSION
This paper describes a method development, 
for assay of benzydamine hydrochloride and meth-
ylparaben in a dosage form of a spray, by gas chro-
matography on an HP-5 capillary column (5% diphe-
nyl-95% dimethylsiloxane) using chloroform extrac-
tion. The total chromatographic time was 17.5 min-
utes. The procedure is specific for the substances to 
be determined. Linearity, repeatability, and accura-
cy of the methodology are proved by validation tests. 
The procedure can be used in routine monitoring 
to determine benzydamine and methylparaben in 
preparations containing these components.
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